Description: Founded in 1981, BioReference Laboratories is a clinical testing laboratory offering a comprehensive menu of services tapped by health care providers interested in the detection, ...

The Web cast will be archived, on both Web sites, for 30 days following the call. About Bio-Reference Laboratories, Inc. The Company is the largest independent regional clinical laboratory in the ...

) announced today that it completed the acquisition of a clinical laboratory in northern California. The Company believes that the California acquisition represents significant strategic value to its ...

What: Shares of Bio-Reference Laboratories, a provider of clinical laboratory testing services, slumped as much as 22% after reporting its preliminary fourth-quarter results and fiscal 2014 full-year ...

Is Bio-Reference Laboratories Inc (NASDAQ:BRLI) a buy? At the moment, there are dozens of gauges market participants can use to analyze the equity markets. A duo of the most under-the-radar are hedge ...

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) (Numbers in Thousands Except Per Share Data or where otherwise noted) released its first quarter, fiscal year 2010 ...

What: Marc D. Grodman, M.D., President and CEO of Bio-Reference Laboratories, Inc. (BRLI) will preside over the closing bell to celebrate the Company's 20th listing anniversary on NASDAQ. Where: ...

ELMWOOD PARK, N.J., April 1, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing agreement for players and staff, stadium ...

ELMWOOD PARK, N.J., April 27, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its renewal as the COVID-19 testing provider for Major League Soccer ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So What: ...